Actinic Cheilitis
10
1
1
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
10.0%
1 terminated out of 10 trials
80.0%
-6.5% vs benchmark
40%
4 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (10)
SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence Tomography
Trichloroacetic Acid as a Topical Treatment for Actinic Cheilitis
Topical Application of Imiquimod Gel at Different Concentrations in Actinic Cheilitis
Evaluation of Ingenol Mebutate for Actinic Cheilitis Treatment
Photodynamic Therapy With Metil 5-aminolevulinate for Actinic Cheilitis - Phase 2 Clinical Trial
Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis
Actinic Cheilitis Pre-Treated With DNA Repair Enzyme Cream
Treatment Study for Actinic Cheilitis Comparing Imiquimod 5% and Photodynamic Therapy
Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Actinic Cheilitis
Photodynamic Therapy to Treat Actinic Damage in Patients With Squamous Cell Carcinoma (SCC) of the Lip